胰腺癌免疫治疗的现状与进展

Current status and progress of immunotherapy for pancreatic cancer

  • 摘要: 胰腺癌是一种常见的消化系统恶性肿瘤, 恶性程度高,预后极差。胰腺癌的治疗方式包括手术切除、化疗、放疗,其手术切除率低,对放化疗敏感性较差,导致5年生存率较低。免疫治疗是一种新型的治疗方式,部分恶性实体肿瘤实施免疫治疗联合其他治疗方式后获得了一定程度的缓解,降期后获得了手术机会,延长了患者总生存期,为胰腺癌的综合治疗带来了希望。本文对胰腺癌免疫治疗联合其他治疗方式的现状与进展进行综述,为胰腺癌的治疗提供参考。

     

    Abstract: Pancreatic cancer is a common malignant tumor of the digestive system. It is discovered late, has a high degree of malignancy, and has an extremely poor prognosis. The treatment of pancreatic cancer includes surgical resection, chemotherapy, and radiotherapy. Due to its low surgical resection rate and poor sensitivity to chemical and radiotherapy, it leads to a low 5-year survival rate. As a new type of treatment, immunotherapy is used to treat some malignant solid tumors in combination with other treatments, and a certain degree of partial remission has been obtained. After the downgrading, the chance of surgery is obtained and the overall survival of the patient is prolonged, and it brings hope for the comprehensive treatment of pancreatic cancer. This article reviewed the research progress and current situation of pancreatic cancer immunotherapy and other treatment methods, and provided reference for the treatment of pancreatic cancer.

     

/

返回文章
返回